Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Foghorn Therapeutics (FHTX – Research Report) yesterday and set a price ...

A new research paper was published in Oncotarget titled, "A nanobody against the V-ATPase c subunit inhibits metastasis of ...

The article, "Autoinhibition of a clamp-loader ATPase revealed by deep mutagenesis and cryo-EM," was published in the journal ...

Lucy Therapeutics Inc. has disclosed new mitochondrial F1F0 ATPase hydrolase inhibitors potentially useful for the treatment of cancer, acute coronary syndrome, ischemia, neurodegeneration and ...

The prize was for the determination of the detailed mechanism by which ATP shuttles energy. The enzyme which makes ATP is called ATP synthase, or ATPase, and sits on the mitochondria in animal cells ...

Elevated sodium levels in tumors boost T-cell metabolic fitness and cytotoxicity, revealing potential avenues for improving ...

Her studies have changed the traditional view of the spontaneous formation of the proteasomal ATPase ring, via revealing conserved novel assembly chaperones for regulating assembly of the ...

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, presented new data on Friday highlighting the impact of alterations in FBXW7, ...

Nonetheless, all remodelers contain a subunit with a conserved ATPase domain. In addition to the conserved ATPase, each remodeler complex also possesses unique proteins that specialize it for its ...

a preclinical Polθ ATPase inhibitor program; as well as additional, undisclosed preclinical programs. For more information, please visit reparerx.com and follow @Reparerx on X (formerly Twitter) and ...

USF faculty continually demonstrate their skills in conducting high-impact research and innovation to advance frontiers of ...